Global In Vitro Diagnostics Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
The Global In Vitro Diagnostics Market is expected to grow from USD 51,253.90 Million in 2018 to USD 76,521.60 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 5.89%.
The positioning of the Global In Vitro Diagnostics Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global In Vitro Diagnostics Market including are Abbott Laboratories, Inc., Agilent Technologies, Arkray, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biom?rieux Sa, Danaher Corporation, Diasorin, Johnson & Johnson, Ortho Clinical Diagnostics, Qiagen, Roche Diagnostics, Siemens AG, Sysmex Corporation, and Thermo Fisher Scientific.
On the basis of Component, the Global In Vitro Diagnostics Market is studied across Data Management Software, Instruments, Reagents & Kits, and Services.
On the basis of Technology, the Global In Vitro Diagnostics Market is studied across Clinical Chemistry, Coagulation & Hemostasis, Hematology, Immunochemistry, Microbiology, Molecular Diagnostics, and Urinalysis.
On the basis of End User, the Global In Vitro Diagnostics Market is studied across Hospitals & Care Providers, Laboratories, and Patient Self-Testing.
On the basis of Application, the Global In Vitro Diagnostics Market is studied across Autoimmune Diseases, Cardiology, Diabetes, Drug Testing, HIV/Aids, Infectious Diseases, Nephrology, and Oncology.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global In Vitro Diagnostics Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global In Vitro Diagnostics Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global In Vitro Diagnostics Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global In Vitro Diagnostics Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global In Vitro Diagnostics Market
The report answers questions such as:
1. What is the market size of In Vitro Diagnostics market in the Global?
2. What are the factors that affect the growth in the Global In Vitro Diagnostics Market over the forecast period?
3. What is the competitive position in the Global In Vitro Diagnostics Market?
4. Which are the best product areas to be invested in over the forecast period in the Global In Vitro Diagnostics Market?
5. What are the opportunities in the Global In Vitro Diagnostics Market?
6. What are the modes of entering the Global In Vitro Diagnostics Market?
The positioning of the Global In Vitro Diagnostics Market vendors in FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global In Vitro Diagnostics Market including are Abbott Laboratories, Inc., Agilent Technologies, Arkray, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biom?rieux Sa, Danaher Corporation, Diasorin, Johnson & Johnson, Ortho Clinical Diagnostics, Qiagen, Roche Diagnostics, Siemens AG, Sysmex Corporation, and Thermo Fisher Scientific.
On the basis of Component, the Global In Vitro Diagnostics Market is studied across Data Management Software, Instruments, Reagents & Kits, and Services.
On the basis of Technology, the Global In Vitro Diagnostics Market is studied across Clinical Chemistry, Coagulation & Hemostasis, Hematology, Immunochemistry, Microbiology, Molecular Diagnostics, and Urinalysis.
On the basis of End User, the Global In Vitro Diagnostics Market is studied across Hospitals & Care Providers, Laboratories, and Patient Self-Testing.
On the basis of Application, the Global In Vitro Diagnostics Market is studied across Autoimmune Diseases, Cardiology, Diabetes, Drug Testing, HIV/Aids, Infectious Diseases, Nephrology, and Oncology.
For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.
In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.
Research Methodology:
Our market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global In Vitro Diagnostics Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global In Vitro Diagnostics Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global In Vitro Diagnostics Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global In Vitro Diagnostics Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global In Vitro Diagnostics Market
The report answers questions such as:
1. What is the market size of In Vitro Diagnostics market in the Global?
2. What are the factors that affect the growth in the Global In Vitro Diagnostics Market over the forecast period?
3. What is the competitive position in the Global In Vitro Diagnostics Market?
4. Which are the best product areas to be invested in over the forecast period in the Global In Vitro Diagnostics Market?
5. What are the opportunities in the Global In Vitro Diagnostics Market?
6. What are the modes of entering the Global In Vitro Diagnostics Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the In Vitro Diagnostics Market
3.2. Opportunities in the In Vitro Diagnostics Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Geriatric population and prevalence of chronic and infectious diseases in Americas
4.2.1.2. Growing awareness on self-testing and personalized medicine
4.2.1.3. Increasing adoption automated instruments and equipment in laboratories
4.2.1.4. Increasing deployment of Point-of-Care testing facilities
4.2.2. Restraints
4.2.2.1. Unfavorable reimbursement
4.2.3. Opportunities
4.2.3.1. Development of condition-specific markers and tests
4.2.3.2. Attractive companion diagnostics
4.2.3.3. Growth opportunities in emerging countries
4.2.4. Challenges
4.2.4.1. Changing the regulatory landscape
4.2.4.2. Operational limitations faced in conducting diagnostic tests
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY COMPONENT
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Data Management Software
5.4. Instruments
5.5. Reagents & Kits
5.6. Services
6. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Clinical Chemistry
6.3.1. Basic Metabolic Panel
6.3.2. Electrolyte Panel
6.3.3. Lipid Profile
6.3.4. Liver Panel
6.3.5. Renal Profile
6.3.6. Specialty Chemical Tests
6.3.7. Thyroid Function Panel
6.4. Coagulation & Hemostasis
6.5. Hematology
6.6. Immunochemistry
6.6.1. Enzyme-Linked Immunosorbent Assay
6.6.1.1. Chemiluminescence Immunoassays
6.6.1.2. Colorimetric Immunoassays
6.6.1.3. Fluorescence Immunoassays
6.6.2. Enzyme-Linked Immunospot Assays
6.6.3. Radioimmunoassay
6.6.4. Rapid Test
6.6.5. Western Blotting
6.7. Microbiology
6.8. Molecular Diagnostics
6.8.1. DNA Sequencing & Next-Generation Sequencing
6.8.2. Hybridization
6.8.3. Isothermal Nucleic Acid Amplification Technology
6.8.4. Microarray
6.8.5. Polymerase Chain Reaction
6.9. Urinalysis
7. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY END USER
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Hospitals & Care Providers
7.4. Laboratories
7.5. Patient Self-Testing
8. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY APPLICATION
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Autoimmune Diseases
8.4. Cardiology
8.5. Diabetes
8.6. Drug Testing
8.7. HIV/Aids
8.8. Infectious Diseases
8.9. Nephrology
8.10. Oncology
9. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY GEOGRAPHY
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. Americas
9.3.1. Overview
9.3.2. Market Sizing & Forecasting
9.3.3. Argentina
9.3.4. Brazil
9.3.5. Canada
9.3.6. Mexico
9.3.7. United States
9.4. Asia-Pacific
9.4.1. Overview
9.4.2. Market Sizing & Forecasting
9.4.3. Australia
9.4.4. China
9.4.5. India
9.4.6. Japan
9.5. Europe, Middle East & Africa
9.5.1. Overview
9.5.2. Market Sizing & Forecasting
9.5.3. France
9.5.4. Germany
9.5.5. Italy
9.5.6. Spain
9.5.7. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. 360iResearch FPNV Positioning Matrix for Global In Vitro Diagnostics Market
10.2. Market Vendor Ranking Analysis for Global In Vitro Diagnostics Market
10.3. Competitive News Feed Analysis for Global In Vitro Diagnostics Market
11. COMPANY USABILITY PROFILES
11.1. Abbott Laboratories, Inc.
11.1.1. Overview
11.1.2. Strategy
11.1.3. SWOT
11.2. Agilent Technologies
11.2.1. Overview
11.2.2. Strategy
11.2.3. SWOT
11.3. Arkray, Inc.
11.3.1. Overview
11.3.2. Strategy
11.3.3. SWOT
11.4. Becton, Dickinson and Company
11.4.1. Overview
11.4.2. Strategy
11.4.3. SWOT
11.5. Bio-Rad Laboratories, Inc.
11.5.1. Overview
11.5.2. Strategy
11.5.3. SWOT
11.6. Biom?rieux Sa
11.7. Danaher Corporation
11.8. Diasorin
11.9. Johnson & Johnson
11.10. Ortho Clinical Diagnostics
11.11. Qiagen
11.12. Roche Diagnostics
11.13. Siemens AG
11.14. Sysmex Corporation
11.15. Thermo Fisher Scientific
12. APPENDIX
12.1. Discussion Guide
12.2. Top Reports
12.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.3. Author Details
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. RESEARCH & FORECASTING
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. EXECUTIVE SUMMARY
3.1. Outlook in the In Vitro Diagnostics Market
3.2. Opportunities in the In Vitro Diagnostics Market
4. PREMIUM INSIGHT
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Geriatric population and prevalence of chronic and infectious diseases in Americas
4.2.1.2. Growing awareness on self-testing and personalized medicine
4.2.1.3. Increasing adoption automated instruments and equipment in laboratories
4.2.1.4. Increasing deployment of Point-of-Care testing facilities
4.2.2. Restraints
4.2.2.1. Unfavorable reimbursement
4.2.3. Opportunities
4.2.3.1. Development of condition-specific markers and tests
4.2.3.2. Attractive companion diagnostics
4.2.3.3. Growth opportunities in emerging countries
4.2.4. Challenges
4.2.4.1. Changing the regulatory landscape
4.2.4.2. Operational limitations faced in conducting diagnostic tests
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY COMPONENT
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Data Management Software
5.4. Instruments
5.5. Reagents & Kits
5.6. Services
6. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Clinical Chemistry
6.3.1. Basic Metabolic Panel
6.3.2. Electrolyte Panel
6.3.3. Lipid Profile
6.3.4. Liver Panel
6.3.5. Renal Profile
6.3.6. Specialty Chemical Tests
6.3.7. Thyroid Function Panel
6.4. Coagulation & Hemostasis
6.5. Hematology
6.6. Immunochemistry
6.6.1. Enzyme-Linked Immunosorbent Assay
6.6.1.1. Chemiluminescence Immunoassays
6.6.1.2. Colorimetric Immunoassays
6.6.1.3. Fluorescence Immunoassays
6.6.2. Enzyme-Linked Immunospot Assays
6.6.3. Radioimmunoassay
6.6.4. Rapid Test
6.6.5. Western Blotting
6.7. Microbiology
6.8. Molecular Diagnostics
6.8.1. DNA Sequencing & Next-Generation Sequencing
6.8.2. Hybridization
6.8.3. Isothermal Nucleic Acid Amplification Technology
6.8.4. Microarray
6.8.5. Polymerase Chain Reaction
6.9. Urinalysis
7. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY END USER
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Hospitals & Care Providers
7.4. Laboratories
7.5. Patient Self-Testing
8. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY APPLICATION
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Autoimmune Diseases
8.4. Cardiology
8.5. Diabetes
8.6. Drug Testing
8.7. HIV/Aids
8.8. Infectious Diseases
8.9. Nephrology
8.10. Oncology
9. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY GEOGRAPHY
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. Americas
9.3.1. Overview
9.3.2. Market Sizing & Forecasting
9.3.3. Argentina
9.3.4. Brazil
9.3.5. Canada
9.3.6. Mexico
9.3.7. United States
9.4. Asia-Pacific
9.4.1. Overview
9.4.2. Market Sizing & Forecasting
9.4.3. Australia
9.4.4. China
9.4.5. India
9.4.6. Japan
9.5. Europe, Middle East & Africa
9.5.1. Overview
9.5.2. Market Sizing & Forecasting
9.5.3. France
9.5.4. Germany
9.5.5. Italy
9.5.6. Spain
9.5.7. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. 360iResearch FPNV Positioning Matrix for Global In Vitro Diagnostics Market
10.2. Market Vendor Ranking Analysis for Global In Vitro Diagnostics Market
10.3. Competitive News Feed Analysis for Global In Vitro Diagnostics Market
11. COMPANY USABILITY PROFILES
11.1. Abbott Laboratories, Inc.
11.1.1. Overview
11.1.2. Strategy
11.1.3. SWOT
11.2. Agilent Technologies
11.2.1. Overview
11.2.2. Strategy
11.2.3. SWOT
11.3. Arkray, Inc.
11.3.1. Overview
11.3.2. Strategy
11.3.3. SWOT
11.4. Becton, Dickinson and Company
11.4.1. Overview
11.4.2. Strategy
11.4.3. SWOT
11.5. Bio-Rad Laboratories, Inc.
11.5.1. Overview
11.5.2. Strategy
11.5.3. SWOT
11.6. Biom?rieux Sa
11.7. Danaher Corporation
11.8. Diasorin
11.9. Johnson & Johnson
11.10. Ortho Clinical Diagnostics
11.11. Qiagen
11.12. Roche Diagnostics
11.13. Siemens AG
11.14. Sysmex Corporation
11.15. Thermo Fisher Scientific
12. APPENDIX
12.1. Discussion Guide
12.2. Top Reports
12.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.3. Author Details
